- Home
- DDI vs CADL Comparison
DDI vs CADL Comparison
Compare DDI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDI | CADL |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.6M | 280.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DDI | CADL |
|---|---|---|
| Price | $8.95 | $5.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $19.00 | ★ $19.14 |
| AVG Volume (30 Days) | 57.3K | ★ 1.3M |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.62 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $125,000.00 |
| Revenue This Year | $6.65 | N/A |
| Revenue Next Year | $2.64 | N/A |
| P/E Ratio | $4.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.09 | $4.25 |
| 52 Week High | $11.25 | $9.01 |
Technical Indicators
Market Signals| Indicator | DDI | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 47.94 |
| Support Level | $8.64 | $4.57 |
| Resistance Level | $9.32 | $5.42 |
| Average True Range (ATR) | 0.35 | 0.24 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 40.22 | 55.98 |
Price Performance
Historical ComparisonAbout DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.